Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome- a pilot study

Gut Microbes. 2021 Jan-Dec;13(1):1-20. doi: 10.1080/19490976.2021.1875774.

Abstract

An increasing body of evidence has shown that gut microbiota imbalances are linked to diseases. Currently, the possibility of regulating gut microbiota to reverse these perturbations by developing novel therapeutic and preventive strategies is being extensively investigated. The modulatory effect of vitamins on the gut microbiome and related host health benefits remain largely unclear. We investigated the effects of colon-delivered vitamins A, B2, C, D, and E on the gut microbiota using a human clinical study and batch fermentation experiments, in combination with cell models for the assessment of barrier and immune functions. Vitamins C, B2, and D may modulate the human gut microbiome in terms of metabolic activity and bacterial composition. The most distinct effect was that of vitamin C, which significantly increased microbial alpha diversity and fecal short-chain fatty acids compared to the placebo. The remaining vitamins tested showed similar effects on microbial diversity, composition, and/or metabolic activity in vitro, but in varying degrees. Here, we showed that vitamins may modulate the human gut microbiome. Follow-up studies investigating targeted delivery of vitamins to the colon may help clarify the clinical significance of this novel concept for treating and preventing dysbiotic microbiota-related human diseases. Trial registration: ClinicalTrials.gov, NCT03668964. Registered 13 September 2018 - Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT03668964.

Keywords: Vitamins; dysbiosis; gut microbiome; targeted delivery.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Ascorbic Acid / administration & dosage
  • Ascorbic Acid / pharmacokinetics
  • Bacteria / classification
  • Bacteria / growth & development*
  • Bacteria / metabolism
  • Caco-2 Cells
  • Colon / metabolism*
  • Colon / microbiology
  • Cytokines / metabolism
  • Dietary Supplements*
  • Double-Blind Method
  • Drug Delivery Systems
  • Fatty Acids, Volatile / metabolism
  • Feces / microbiology
  • Fermentation
  • Gastrointestinal Microbiome / physiology*
  • HT29 Cells
  • Humans
  • Pilot Projects
  • Riboflavin / administration & dosage
  • Riboflavin / pharmacokinetics
  • Vitamin A / administration & dosage
  • Vitamin A / pharmacokinetics
  • Vitamin D / administration & dosage
  • Vitamin D / pharmacokinetics
  • Vitamin E / administration & dosage
  • Vitamin E / pharmacokinetics
  • Vitamins / administration & dosage*
  • Vitamins / pharmacokinetics

Substances

  • Cytokines
  • Fatty Acids, Volatile
  • Vitamins
  • Vitamin A
  • Vitamin D
  • Vitamin E
  • Ascorbic Acid
  • Riboflavin

Associated data

  • ClinicalTrials.gov/NCT03668964